Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

SELL
$26.24 - $39.63 $512,808 - $774,489
-19,543 Reduced 28.08%
50,050 $1.97 Million
Q1 2023

Apr 28, 2023

BUY
$18.67 - $24.56 $364,867 - $479,976
19,543 Added 39.05%
69,593 $1.69 Million
Q1 2021

Apr 27, 2021

BUY
$5.08 - $6.89 $254 - $344
50 Added 0.1%
50,050 $309,000
Q4 2020

Jan 25, 2021

BUY
$5.65 - $7.66 $282,500 - $383,000
50,000 New
50,000 $346,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.